1. Home
  2. CLDX vs GABC Comparison

CLDX vs GABC Comparison

Compare CLDX & GABC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CLDX
  • GABC
  • Stock Information
  • Founded
  • CLDX N/A
  • GABC 1910
  • Country
  • CLDX United States
  • GABC United States
  • Employees
  • CLDX N/A
  • GABC N/A
  • Industry
  • CLDX Biotechnology: In Vitro & In Vivo Diagnostic Substances
  • GABC Major Banks
  • Sector
  • CLDX Health Care
  • GABC Finance
  • Exchange
  • CLDX Nasdaq
  • GABC Nasdaq
  • Market Cap
  • CLDX 1.3B
  • GABC 1.4B
  • IPO Year
  • CLDX 2008
  • GABC N/A
  • Fundamental
  • Price
  • CLDX $20.66
  • GABC $38.19
  • Analyst Decision
  • CLDX Buy
  • GABC Hold
  • Analyst Count
  • CLDX 9
  • GABC 3
  • Target Price
  • CLDX $50.00
  • GABC $45.33
  • AVG Volume (30 Days)
  • CLDX 843.8K
  • GABC 112.0K
  • Earning Date
  • CLDX 08-07-2025
  • GABC 07-28-2025
  • Dividend Yield
  • CLDX N/A
  • GABC 3.04%
  • EPS Growth
  • CLDX N/A
  • GABC N/A
  • EPS
  • CLDX N/A
  • GABC 2.62
  • Revenue
  • CLDX $5,790,000.00
  • GABC $281,091,000.00
  • Revenue This Year
  • CLDX N/A
  • GABC $45.58
  • Revenue Next Year
  • CLDX N/A
  • GABC $6.01
  • P/E Ratio
  • CLDX N/A
  • GABC $14.53
  • Revenue Growth
  • CLDX N/A
  • GABC 13.87
  • 52 Week Low
  • CLDX $14.40
  • GABC $32.75
  • 52 Week High
  • CLDX $47.00
  • GABC $47.08
  • Technical
  • Relative Strength Index (RSI)
  • CLDX 40.75
  • GABC 40.38
  • Support Level
  • CLDX $20.65
  • GABC $37.40
  • Resistance Level
  • CLDX $22.60
  • GABC $38.90
  • Average True Range (ATR)
  • CLDX 1.11
  • GABC 0.85
  • MACD
  • CLDX -0.28
  • GABC -0.24
  • Stochastic Oscillator
  • CLDX 10.64
  • GABC 34.39

About CLDX Celldex Therapeutics Inc.

Celldex Therapeutics Inc is a biopharmaceutical company. It is focused on the development and commercialization of several immunotherapy technologies and other cancer-targeting biologics. The company is also engaged in clinical trials for products targeting breast cancer, metastatic melanoma, lung cancer, solid tumors, and ovarian cancer. It has single operating and reportable segment that operates in the business of development, manufacturing and commercialization of novel therapeutics for human health care.

About GABC German American Bancorp Inc.

German American Bancorp Inc is a bank holding company. The lines of business include Retail and commercial banking business which involves attracting deposits from the general public and using those funds to originate consumer, commercial and agricultural, commercial and agricultural real estate, and residential mortgage loans. These core banking activities also include the sale of residential mortgage loans in the secondary market. Wealth management services which involve providing trust, investment advisory, brokerage and retirement planning services to customers. Insurance operations include the offering of a full range of personal and corporate property and casualty insurance products.

Share on Social Networks: